Beta
197742

Protective effects of coenzyme Q10 against cisplatin-induced toxicity on testis in experimental rats

Article

Last updated: 22 Jan 2023

Subjects

-

Tags

Natural/synthetic agents in anti-cancer therapy

Abstract

Background: Cisplatin is an anti-cancer drug that is associated with testicular toxicity because of its induction of excessive reactive oxygen species. Coenzyme Q10 (CoQ10) has been found to express antioxidant and anti-inflammatory effects. Aim: This study aims to investigate if CoQ10 can counter the testicular tissue toxicity caused by cisplatin. Materials and Methods: Animals were weighed and randomly divided into four groups (n = 10/each).  In group I (control group), rats were received 1% of Tween-80 through intraperitoneal (i.p.) injection for 15 days. Group II (CoQ10 group) were i.p. treated for 15 days with CoQ10 in 1% tween-80 at a dosage of 10mg/kg/day for 15 days.  Rats in group III (Cisplatin group) were i.p. treated with a single i.p. injection of cisplatin at a dosage of 7mg/kg on the 5th day of the experiment. Group IV (CoQ10/cisplatin) were i.p. treated with CoQ10 at a dosage of 10mg/kg/day for 15 days and cisplatin at a dosage of 7mg/kg on the 5th day of the experiment. Biochemical measurements as well as histological and immunohistochemical morphometric were done. Results: CoQ10 diminished cisplatin induced oxidative stress through reducing lipid peroxidation and nitric oxide levels and increasing the levels of antioxidant enzymes, including superoxide dismutase and glutathione dehydrogenase. Moreover, CoQ10 significantly decreased the inflammatory response to cisplatin administration by decreasing the proinflammatory mediator tumor necrosis factor-α and increasing the anti-inflammatory cytokine IL-10. Treatment with CoQ10 also induced significant improvement in histopathological changes in testes. Conclusion: CoQ10 could protect testes against cisplatin induced injury.

DOI

10.21608/jcbr.2021.79891.1224

Keywords

Coenzyme Q10, Cisplatin, Rat & Testis

Authors

First Name

Huda

Last Name

Abd-Elhafiz

MiddleName

-

Affiliation

Clinical Pharmacology Department, Faculty of Medicine, Menoufia University, Egypt.

Email

hoda.break@med.menofia.edu.eg

City

-

Orcid

-

First Name

Noha

Last Name

Issa

MiddleName

-

Affiliation

Anatomy and Embryology Department, Faculty of Medicine, Menoufia University, Egypt.

Email

drnohaissa@yahoo.com

City

-

Orcid

-

First Name

Eman

Last Name

Sweed

MiddleName

-

Affiliation

Clinical Pharmacology Department, Faculty of Medicine, Menoufia University, Egypt.

Email

eman.sweed@med.menofia.edu.eg

City

-

Orcid

0000-0003-3689-2648

Volume

5

Article Issue

4

Related Issue

29244

Issue Date

2021-12-01

Receive Date

2021-08-06

Publish Date

2021-12-01

Page Start

109

Page End

120

Print ISSN

2682-261X

Online ISSN

2682-2628

Link

https://jcbr.journals.ekb.eg/article_197742.html

Detail API

https://jcbr.journals.ekb.eg/service?article_code=197742

Order

9

Type

Original Article

Type Code

885

Publication Type

Journal

Publication Title

International Journal of Cancer and Biomedical Research

Publication Link

https://jcbr.journals.ekb.eg/

MainTitle

-

Details

Type

Article

Created At

22 Jan 2023